Exploring Cannabinoids as Potential Inhibitors of SARS-CoV-2 Papain-like Protease: Insights from Computational Analysis and Molecular Dynamics Simulations
Viruses · 2024
DOI: 10.3390/v16060878 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Jamie Holmes und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Delaware State University, 1200 N. DuPont Hwy, Dover, DE 19901, USA. Hauptthemen laut MEDLINE: Antiviral Agents, Cannabinoids, SARS-CoV-2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIMHD NIH HHS, Delaware State University-HGBI Fellowship.
Abstract (Originalsprache)
The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has triggered a global COVID-19 pandemic, challenging healthcare systems worldwide. Effective therapeutic strategies against this novel coronavirus remain limited, underscoring the urgent need for innovative approaches. The present research investigates the potential of cannabis compounds as therapeutic agents against SARS-CoV-2 through their interaction with the virus’s papain-like protease (PLpro) protein, a crucial element in viral replication and immune evasion. Computational methods, including molecular docking and molecular dynamics (MD) simulations, were employed to screen cannabis compounds against PLpro and analyze their binding mechanisms and interaction patterns. The results showed cannabinoids with binding affinities ranging from −6.1 kcal/mol to −4.6 kcal/mol, forming interactions with PLpro. Notably, Cannabigerolic and Cannabidiolic acids exhibited strong binding contacts with critical residues in PLpro’s active region, indicating their potential as viral replication inhibitors. MD simulations revealed the dynamic behavior of cannabinoid–PLpro complexes, highlighting stable binding conformations and conformational changes over time. These findings shed light on the mechanisms underlying cannabis interaction with SARS-CoV-2 PLpro, aiding in the rational design of antiviral therapies. Future research will focus on experimental validation, optimizing binding affinity and selectivity, and preclinical assessments to develop effective treatments against COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Delaware State University, 1200 N. DuPont Hwy, Dover, DE 19901, USA.
ORCID-Profile: Shahidul M Islam
Förderung
- NIGMS NIH HHS
- NIMHD NIH HHS
- Delaware State University-HGBI Fellowship
- National Institutes of Health
- COBRE
- DE-INBRE
- National Science Foundation
Zitieren
APA
Holmes, J., Islam, S. M., & Milligan, K. A. (2024). Exploring Cannabinoids as Potential Inhibitors of SARS-CoV-2 Papain-like Protease: Insights from Computational Analysis and Molecular Dynamics Simulations. Viruses. https://doi.org/10.3390/v16060878
Vancouver
Holmes J, Islam SM, Milligan KA. Exploring Cannabinoids as Potential Inhibitors of SARS-CoV-2 Papain-like Protease: Insights from Computational Analysis and Molecular Dynamics Simulations. Viruses. 2024. doi:10.3390/v16060878
BibTeX
@article{Holmes2024,
author = {Holmes, Jamie and Islam, Shahidul M and Milligan, Kimberly A},
title = {Exploring Cannabinoids as Potential Inhibitors of SARS-CoV-2 Papain-like Protease: Insights from Computational Analysis and Molecular Dynamics Simulations},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16060878}
}
EUVIMED